Abstract
In vivo tumor growth data from experiments performed in our laboratory suggest that basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are angiogenic signals emerging from an up-regulated genetic message in the proliferating rim of a solid tumor in response to tumor-wide hypoxia. If these signals are generated in response to unfavorable environmental conditions, i.e. a decrease in oxygen tension, then the tumor may play an active role in manipulating its own environment. We have idealized this type of adaptive behavior in our mathematical model via a parameter which represents the carrying capacity of the host for the tumor. If that model parameter is held constant, then environmental control is limited to tumor shape and mitogenic signal processing. However, if we assume that the response of the local stroma to these signals is an increase in the host's ability to support an ever larger tumor, then our models describe a positive feedback control system. In this paper, we generalize our previous results to a model including a carrying capacity which depends on the size of the proliferating compartment in the tumor. Specific functional forms for the carrying capacity are discussed. Stability criteria of the system and steady state conditions for these candidate functions are analyzed. The dynamics needed to generate stable tumor growth, including countervailing negative feedback signals, are discussed in detail with respect to both their mathematical and biological properties.
Similar content being viewed by others
References
Adam, J. A. and S. A. Megalakis. 1990. Diffusion regulated growth characteristics of the spherical prevascular carcinoma.Bull. Math. Biol. 52, 549–582.
Bajzer, Z. and S. Vuk-Pavlovic. 1990. Quantitative aspects of autocrine regulation in tumors.Crit. Rev. Oncogenesis 2, 53–73.
Byrne, H. M. and M. A. J. Chaplain. 1995. Mathematical models for tumour angiogenesis: numerical simulations and nonlinear wave solutions.Bull. Math. Biol. 57, 461–486.
Ciampi, A., L. Kates, R. Buick, Y. Kruikov and J. E. Till. 1986. Multi-type Galton-Watson process as a model for proliferating human tumour cell populations derived from stem cells: estimation of the stem cell self-renewal probabilities in human ovarian carcinomas.Cell Tissue Kinet. 19, 129–140.
Day, R. S. 1986. A branching process model for heterogeneous cell populations.Math. Biosci. 78, 73–90.
Goustin, A. S., E. B. Loef, G. D. Shipley and H. L. Moses. 1986. Growth factors and cancer.Cancer Res. 46, 1015–1029.
Gyllenberg, M. and G. F. Webb. 1989. Quiescence as an explanation of Gompertzian tumor growth. Technical Report MAT-A264, Vanderbilt University.
Heppner, G. H. 1984. Tumor heterogeneity.Cancer Res. 44, 2259–2265.
Kendal, W. S. 1985. Gompertzian growth as a consequence of tumor heterogeneity.Math Biosci. 73, 103–107.
Keski-Oja, J., A. E. Postlethwaite and H. L. Moses. 1988. Transforming growth factors in the regulation of malignant cell growth and invasion.Cancer Investigations 6, 705–724.
Leith, J. T. and S. Michelson. 1990. Tumor radiocurability: relationship to intrinsic tumor heterogeneity and the tumor bed effect.Inv. Metast. 10, 329–351.
Leith, J. T. and S. Michelson. 1995a. Levels of selected growth factors in viable and necrotic regions of xenografted HCT-8 human colon tumours.Cell Proliferation 28, 279–286.
Leith, J. T. and S. Michelson. 1995b. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumor cells as a function of oxygen concentration. Unpublished manuscript.
Leith, J. T., G. Papa, L. Quaranto and S. Michelson. 1992. Modification of the volumetric growth responses and steady state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.Br. J. Cancer 66, 345–348.
Loef, E. B., J. A. Proper, A. S. Goustin, G. D. Shipley, P. E. DiCorleto and H. L. Moses. 1986. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity.Proc. Nat. Acad. Sci. USA 83, 2453–2457.
Marusic, M. and S. Vuk-Pavlovic. 1993. Prediction power of mathematical models of tumor growth.J. Biol. Syst. 1, 69–78.
Marusic, M., Z. Bajzer, J. P. Freyer and S. Vuk-Pavlovic. 1991. Modeling autostimulation of growth in multicellular tumor spheroids.Int. J. Biomed. Comput. 29, 149–158.
Marusic, M., Z. Bajzer, S. Vuk-Pavlovic and J. R. Freyer. 1994. Tumor growth.In vivo and as multicellular spheroids compared by mathematical models.Bull. Math. Biol. 56, 617–632.
McCarty, L. P., S. Karr, S. Michelson and J. T. Leith. 1995. Comparison of FGF-2 levels in clone A human colon cancer cellsin vitro versus levels in xenografted tumours.Br. J. Cancer 72, 10–16.
Mead, J. E. and N. Fausto. 1989. Transforming growth factor alpha may be a physiological regulator of liver regeneration by means of an autocrine mechanism.Proc. Nat. Acad. Sci. USA 86, 1558–1562.
Michelson, S. and J. T. Leith. 1991. Autocrine and paracrine growth factors in tumor growth.Bull. Math. Biol. 53, 639–656.
Michelson, S. and J. T. Leith. 1992. Growth factors and growth control of heterogeneous cell populations.Bull. Math. Biol. 55, 993–1011.
Michelson, S. and J. T. Leith. 1994. Dormancy, regression, and recurrence: towards a unifying theory of tumor growth control.J. Theor. Biol. 169, 327–338.
O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Chao, E. H. Sage and J. Folkman. 1995. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.Cell 79, 315–328.
Piantadosi, S. 1985. A model of tumor growth with first-order birth and death rates.Comp. Biomed. Res. 18, 220–232.
Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern and M. B. Sporn. 1985. Type beta transforming growth factor: a bifunctional regulator of cellular growth.Proc. Nat. Acad. Sci. USA 82, 119–123.
Rockwell, S. 1981. Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors.Cancer Res. 41, 527.
Rosen, R. 1978. Feedforwards and global systems failure: a generalized mechanism for senescence.J. Theor. Biol. 74, 579–590.
Sporn, M. B. and A. B. Roberts. 1985. Autocrine growth factors and cancer.Nature 313, 745–747.
Sporn, M. B. and G. J. Todaro. 1980. Autocrine secretion and malignant transformation of cells.New Engl. J. Med. 303, 878–880.
Truco, E. 1965a. Mathematical models for cellular systems: the Von Foerster equation. Part I.Bull. Math. Biophys. 27, 283–303.
Truco, E. 1965b. Mathematical models for cellular systems: the Von Foerster equation. Part II.Bull. Math. Biophys. 27, 449–471.
Vaidya, P. G., V. G. Vaidya and D. G. Martin. 1991. An application of the nonlinear bifurcation theory to tumor growth modeling.Int. J. Biomed. Comput. 27, 27–46.
Von Foerster, H. 1959. Some remarks on changing populations. InThe Kinetics of Cellular Proliferation, F. Stohlman (Ed). Grune and Stratton, New York.
Wette, R., I. N. Katz and E. Y. Rodin, 1974a. Stochastic processes for solid tumor kinetics I. Surface regulated growth.Math. Biosci. 19, 231–255.
Watte, R., I. N. Katz and E. Y. Rodin. 1974b. Stochastic processes for solid tumor kinetics II. Diffusion regulated growth.Math. Biosci. 19, 311–338.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Michelson, S., Leith, J.T. Positive feedback and angiogenesis in tumor growth control. Bltn Mathcal Biology 59, 233–254 (1997). https://doi.org/10.1007/BF02462002
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02462002